Drug Type AAV based gene therapy |
Synonyms oncolytic adenovirus therapy expressing p53 + GM-CSF + B7.1(Tianjin Hi-Tech/The Institute of Radiation Medicine), oncolytic adenovirus therapy expressing p53 + GM-CSF + CD28 costimulator(Tianjin Hi-Tech/The Institute of Radiation Medicine) |
Target |
Mechanism CD28 agonists(T-cell-specific surface glycoprotein CD28 agonists), CD80 modulators(Cluster of differentiation 80 modulators), p53 modulators(Tumor protein p53 modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |